| Markers of pancreatic cancer stem cells and their clinical and therapeutic implications A Gzil, I Zarębska, W Bursiewicz, P Antosik, D Grzanka, Ł Szylberg Molecular biology reports 46, 6629-6645, 2019 | 105 | 2019 |
| Diagnosis of Hirschsprung’s disease with particular emphasis on histopathology. A systematic review of current literature Ł Szylberg, A Marszałek Gastroenterology Review/Przegląd Gastroenterologiczny 9 (5), 264-269, 2014 | 82 | 2014 |
| Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review Ł Szylberg, M Janiczek, A Popiel, A Marszałek Gastroenterology research and practice 2015, 2015 | 69 | 2015 |
| Immunotherapy as a promising treatment for prostate cancer: a systematic review M Janiczek, Ł Szylberg, A Kasperska, A Kowalewski, M Parol, P Antosik, ... Journal of immunology research 2017, 2017 | 60 | 2017 |
| Emerging strategies in BRCA-positive pancreatic cancer A Kowalewski, Ł Szylberg, M Saganek, W Napiontek, P Antosik, ... Journal of Cancer Research and Clinical Oncology 144, 1503-1507, 2018 | 52 | 2018 |
| The role of FOXP3 in human cancers Ł Szylberg, D Karbownik, A Marszałek Anticancer research 36 (8), 3789-3794, 2016 | 51 | 2016 |
| Deep anterior cerebellar stimulation reduces symptoms of secondary dystonia in patients with cerebral palsy treated due to spasticity P Sokal, M Rudaś, M Harat, Ł Szylberg, P Zieliński Clinical neurology and neurosurgery 135, 62-68, 2015 | 49 | 2015 |
| Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors M Bodnar, Ł Szylberg, W Kazmierczak, A Marszalek Journal of Oral Pathology & Medicine 44 (6), 437-443, 2015 | 45 | 2015 |
| Do mesenchymal stem cells modulate the milieu of reconstructed bladder wall? M Pokrywczynska, A Jundzill, M Bodnar, J Adamowicz, J Tworkiewicz, ... Archivum immunologiae et therapiae experimentalis 61, 483-493, 2013 | 42 | 2013 |
| Impact of COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesisin the large bowel A Marszałek, Ł Szylberg, E Wiśniewska, M Janiczek Polish Journal of Pathology 63 (4), 221-227, 2012 | 32 | 2012 |
| Differentiated expression of membrane type metalloproteinases (MMP‐14, MMP‐15) and pro‐MMP 2 in laryngeal squamous cell carcinoma. A novel mechanism M Bodnar, L Szylberg, W Kazmierczak, A Marszalek Journal of oral pathology & medicine 42 (3), 267-274, 2013 | 29 | 2013 |
| The role of inflammatory cytokines in the pathogenesis of colorectal carcinoma—recent findings and review J Borowczak, K Szczerbowski, M Maniewski, A Kowalewski, ... Biomedicines 10 (7), 1670, 2022 | 26 | 2022 |
| The diagnosis and management of congenital and adult-onset hyperinsulinism (nesidioblastosis)–literature review AM Kowalewski, Ł Szylberg, A Kasperska, A Marszałek Polish Journal of Pathology 68 (2), 97-101, 2017 | 26 | 2017 |
| Proteomic profiling identifies the inorganic pyrophosphatase (PPA1) protein as a potential biomarker of metastasis in laryngeal squamous cell carcinoma M Bodnar, M Luczak, K Bednarek, L Szylberg, A Marszalek, R Grenman, ... Amino Acids 48, 1469-1476, 2016 | 26 | 2016 |
| Expression of COX-2, IL-1β, TNF-α and IL-4 in epithelium of serrated adenoma, adenoma and hyperplastic polyp Ł Szylberg, M Janiczek, A Popiel, A Marszałek Archives of Medical Science 12 (1), 172-178, 2016 | 26 | 2016 |
| Expression of metalloproteinases 2 and 9 and tissue inhibitors 1 and 2 as predictors of lymph node metastases in oropharyngeal squamous cell carcinoma PK Burduk, M Bodnar, P Sawicki, Ł Szylberg, E Wiśniewska, ... Head & Neck 37 (3), 418-422, 2015 | 26 | 2015 |
| Large bowel genetic background and inflammatory processes in carcinogenesis–systematic review L Szylberg, M Janiczek, A Popiel, A Marszałek Adv. Clin. Exp. Med 24 (4), 555-563, 2015 | 23 | 2015 |
| Clinical relevance of BRAF V600E mutation status in brain tumors with a focus on a novel management algorithm A Kowalewski, J Durślewicz, M Zdrenka, D Grzanka, Ł Szylberg Targeted Oncology 15, 531-540, 2020 | 17 | 2020 |
| Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation E Byzia, N Soloch, M Bodnar, M Szaumkessel, K Kiwerska, ... Molecular Carcinogenesis 57 (7), 878-885, 2018 | 17 | 2018 |
| MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study M Szylberg, P Sokal, P Śledzińska, M Bebyn, S Krajewski, Ł Szylberg, ... Biomedicines 10 (8), 2030, 2022 | 16 | 2022 |
